|
GARIN5A
|
golgi associated RAB2 interactor 5A |
|
|
|
|
GHR
|
growth hormone receptor |
- Prolactin receptor signaling
- Growth hormone receptor signaling
- Growth hormone receptor signaling
|
- Somatotropin
- Pegvisomant
- Somatrem
- Somapacitan
- Lonapegsomatropin
|
- Pituitary Dwarfism (PD); Isolated growth hormone deficiency (IGHD); Short Stature and Pituitary Defects (SSPD); Insulin-like growth factor 1 deficiency (IGFD)
|
|
GMNN
|
geminin DNA replication inhibitor |
- Assembly of the pre-replicative complex
- Activation of the pre-replicative complex
- Switching of origins to a post-replicative state
|
|
|
|
GOLGA2
|
golgin A2 |
- Golgi Cisternae Pericentriolar Stack Reorganization
- Golgi Cisternae Pericentriolar Stack Reorganization
- COPII-mediated vesicle transport
- COPI-mediated anterograde transport
- Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
|
|
|
|
GRB2
|
growth factor receptor bound protein 2 |
- Interleukin-15 signaling
- Interleukin-15 signaling
- Signaling by CSF3 (G-CSF)
- Signaling by CSF3 (G-CSF)
- STAT5 activation downstream of FLT3 ITD mutants
- Signaling by FLT3 ITD and TKD mutants
- Signaling by FLT3 ITD and TKD mutants
- Signaling by ALK fusions and activated point mutants
- Signaling by LTK
|
- Pegademase
- 4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid
|
|
|
GRIN2B
|
glutamate ionotropic receptor NMDA type subunit 2B |
- EPHB-mediated forward signaling
- EPHB-mediated forward signaling
- Unblocking of NMDA receptors, glutamate binding and activation
- Unblocking of NMDA receptors, glutamate binding and activation
- Ras activation upon Ca2+ influx through NMDA receptor
- RAF/MAP kinase cascade
- Neurexins and neuroligins
- Synaptic adhesion-like molecules
- MECP2 regulates neuronal receptors and channels
- Activated NTRK2 signals through FYN
- Assembly and cell surface presentation of NMDA receptors
- Assembly and cell surface presentation of NMDA receptors
- Negative regulation of NMDA receptor-mediated neuronal transmission
- Long-term potentiation
|
- Glutamic acid
- Tramadol
- Enflurane
- Atomoxetine
- Pentobarbital
- Methadone
- Secobarbital
- Meperidine
- Haloperidol
- Dextropropoxyphene
- Acamprosate
- Donepezil
- Guaifenesin
- Felbamate
- Memantine
- Phenobarbital
- Aripiprazole
- Tenocyclidine
- Prasterone
- Taurine
- Milnacipran
- EVT-101
- Lumateperone
- Acetylcysteine
- Ketobemidone
- Gavestinel
- Ifenprodil
- Magnesium acetate tetrahydrate
- Magnesium carbonate
- Esketamine
- Esketamine
- Fluciclovine (18F)
|
|
|
GTF2A2
|
general transcription factor IIA subunit 2 |
- HIV Transcription Initiation
- RNA Polymerase II HIV Promoter Escape
- Transcription of the HIV genome
- RNA Polymerase II Pre-transcription Events
- RNA polymerase II transcribes snRNA genes
- RNA polymerase II transcribes snRNA genes
- RNA Polymerase II Promoter Escape
- RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
- RNA Polymerase II Transcription Initiation
- RNA Polymerase II Transcription Initiation And Promoter Clearance
- Estrogen-dependent gene expression
|
|
|
|
HNRNPU
|
heterogeneous nuclear ribonucleoprotein U |
- mRNA Splicing - Major Pathway
- Processing of Capped Intron-Containing Pre-mRNA
- Transcriptional regulation of brown and beige adipocyte differentiation by EBF2
|
|
|
|
HSP90B1
|
heat shock protein 90 beta family member 1 |
- Trafficking and processing of endosomal TLR
- Scavenging by Class A Receptors
- Scavenging by Class A Receptors
- ATF6 (ATF6-alpha) activates chaperone genes
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- Interleukin-4 and Interleukin-13 signaling
- Post-translational protein phosphorylation
|
- Rifabutin
- 2-Chlorodideoxyadenosine
- Geldanamycin
- Diglyme
- N-Ethyl-5'-Carboxamido Adenosine
- Radicicol
- METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE
- 2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE
- Copper
|
|
|
HSPA5
|
heat shock protein family A (Hsp70) member 5 |
- Platelet degranulation
- Regulation of HSF1-mediated heat shock response
- ATF6 (ATF6-alpha) activates chaperones
- PERK regulates gene expression
- IRE1alpha activates chaperones
- ATF6 (ATF6-alpha) activates chaperone genes
- ATF6B (ATF6-beta) activates chaperones
- Antigen Presentation: Folding, assembly and peptide loading of class I MHC
- Antigen Presentation: Folding, assembly and peptide loading of class I MHC
- Modulation of host responses by IFN-stimulated genes
|
- Antihemophilic factor, human recombinant
- Acetylsalicylic acid
- Copper
- Lonoctocog alfa
- Moroctocog alfa
|
|
|
HSPA9
|
heat shock protein family A (Hsp70) member 9 |
- Mitochondrial protein import
- Regulation of HSF1-mediated heat shock response
- Complex I biogenesis
- Cristae formation
- Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
- Mitochondrial protein degradation
- Mitochondrial unfolded protein response (UPRmt)
- Complex III assembly
|
|
|
|
HSPD1
|
heat shock protein family D (Hsp60) member 1 |
- Mitochondrial protein import
- Mitochondrial protein import
- TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation
- Mitochondrial protein degradation
- Mitochondrial unfolded protein response (UPRmt)
|
|
- Hypomyelinating leukodystrophy (HLD); Pelizaeus-Merzbacher disease (PMD)
- Hereditary spastic paraplegia (SPG)
|
|
IFNAR1
|
interferon alpha and beta receptor subunit 1 |
- Interferon alpha/beta signaling
- Regulation of IFNA/IFNB signaling
- Regulation of IFNA/IFNB signaling
- Potential therapeutics for SARS
- SARS-CoV-2 activates/modulates innate and adaptive immune responses
- Evasion by RSV of host interferon responses
|
- Peginterferon alfa-2a
- Interferon alfa-n1
- Interferon alfa-n3
- Peginterferon alfa-2b
- Interferon alfa-2a
- Interferon beta-1a
- Interferon beta-1b
- Interferon alfacon-1
- Interferon alfa-2b
- Interferon alfa
- Human interferon omega-1
- Peginterferon beta-1a
- Anifrolumab
- Human interferon beta
- Ropeginterferon alfa-2b
|
|
|
IFNGR1
|
interferon gamma receptor 1 |
- Interferon gamma signaling
- Regulation of IFNG signaling
- Regulation of IFNG signaling
- Potential therapeutics for SARS
- IFNG signaling activates MAPKs
|
|
- Tuberculosis
- IFN-gamma/IL-12 axis, including the following five diseases: IL-12 p40 subunit deficiency; IL-12 receptor (IL-12R) beta1 chain deficiency; IFN-gamma receptor (IFN gamma R) alpha chain deficiency; IFN-gamma receptor (IFN gamma R) beta chain deficiency; STAT-1 deficiency
|
|
IGF1R
|
insulin like growth factor 1 receptor |
- Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
- IRS-related events triggered by IGF1R
- SHC-related events triggered by IGF1R
- Extra-nuclear estrogen signaling
- Respiratory syncytial virus (RSV) attachment and entry
|
- Insulin human
- Insulin lispro
- Insulin glargine
- Insulin pork
- Mecasermin
- Insulin aspart
- Insulin detemir
- Insulin glulisine
- Phosphoaminophosphonic Acid-Adenylate Ester
- ATL1101
- XL228
- rhIGFBP-3
- Linsitinib
- Teprotumumab
- (4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione
- 3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE
- Nandrolone decanoate
- Somatrem
- Insulin beef
- Insulin degludec
- Insulin argine
- Insulin peglispro
- Insulin tregopil
- Dalotuzumab
- Cixutumumab
- Brigatinib
- Mecasermin rinfabate
- BMS-754807
- KW-2450 free base
|
- Synovial sarcoma
- Malignant pleural mesothelioma
|
|
IL4R
|
interleukin 4 receptor |
- Interleukin-4 and Interleukin-13 signaling
|
|
|
|
IL6ST
|
interleukin 6 cytokine family signal transducer |
- Interleukin-6 signaling
- Interleukin-6 signaling
- IL-6-type cytokine receptor ligand interactions
- Interleukin-35 Signalling
- Interleukin-27 signaling
- Interleukin-27 signaling
|
|
|
|
ILK
|
integrin linked kinase |
- Localization of the PINCH-ILK-PARVIN complex to focal adhesions
- Cell-extracellular matrix interactions
|
|
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase D |
- Synthesis of PIPs at the plasma membrane
- Synthesis of IP3 and IP4 in the cytosol
- Downstream TCR signaling
- PECAM1 interactions
- Interleukin receptor SHC signaling
- Signaling by CSF1 (M-CSF) in myeloid cells
|
|
|
|
INSR
|
insulin receptor |
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- IRS activation
- Signal attenuation
- Insulin receptor signalling cascade
- Signaling by Insulin receptor
- Insulin receptor recycling
|
- Insulin human
- Insulin lispro
- Insulin glargine
- Insulin pork
- Mecasermin
- Insulin aspart
- Insulin detemir
- Insulin glulisine
- Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate
- NN344
- AT1391
- Linsitinib
- [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID
- Chromic chloride
- Insulin beef
- Insulin degludec
- Insulin argine
- Insulin peglispro
- Insulin tregopil
- Fostamatinib
- Brigatinib
- Mecasermin rinfabate
- BMS-754807
- KW-2450 free base
|
- Leprechaunism ; Donohue syndrome
- Rabson-Mendenhall syndrome
|